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Abstract
Background. Disordered eating (DE) is a widespread, serious problem. Efficacious prevention
programs that can be delivered at-scale are needed.
Methods. A pragmatic randomized controlled trial of two online programs was conducted.
Participants were young-adult women from Australia and New Zealand seeking to improve
their body image. Media Smart-Targeted (MS-T) and Student Bodies (SB) were both 9-module
interventions released weekly, whilst control participants received positive body image information. Primary [Eating Disorder Examination–Questionnaire (EDE-Q) Global], secondary
(DE risk factors) and tertiary (DE) outcome measures were completed at baseline, post-program, 6- and 12-month follow-up.
Results. Baseline was completed by 608 women (M age = 20.71 years); 33 were excluded leaving 575 randomized to: MS-T (N = 191); SB (N = 190) or control (N = 194). Only 66% of those
randomized to MS-T or SB accessed the intervention and were included in analyses with controls; 78% of this sample completed measures subsequent to baseline. Primary intent-to-treat
(ITT) analyses revealed no differences between groups, while measure completer analyses
found MS-T had significantly lower EDE-Q Global than controls at 12-month follow-up.
Secondary ITT analyses found MS-T participants reported significantly higher quality of
life–mental relative to both SB and controls (6-month follow-up), while MS-T and controls
had lower clinical impairment relative to SB (post-program). Amongst measure completers,
MS-T scored significantly lower than controls and SB on 5 variables. Of those with baseline
DE, MS-T participants were significantly less likely than controls to have DE at 12-month follow-up.
Conclusions. Given both programs were not therapist-moderated, MS-T has potential to
achieve reductions in DE risk at low implementation costs.

Introduction

© Cambridge University Press 2017

Disordered eating (DE) refers to sub-threshold variants of threshold eating disorders (TED:
e.g., anorexia nervosa, bulimia nervosa and binge eating disorder) and include behaviours
such as fasting, binge eating, vomiting, laxative use, or maintaining body mass index (BMI)
< 18.5, in addition to substantial concerns about food, body weight and shape. The pursuit
of efficacious DE risk reduction is of critical importance for many reasons (Wilksch, 2014;
Austin, 2016). First, DE can be a risk factor for the development of TED (Patton et al.
1999; Wertheim et al. 2001; Stice et al. 2008a). Second, the prevalent nature of DE, as highlighted by an Australian cohort study (N = 9688) where DE was observed in 23% of youngadult women (Wade et al. 2012). Third, evidence suggests those with DE experience similar
impairment in functioning and quality of life as those with TED (Fairburn & Cooper, 2011;
Fairweather-Schmidt & Wade, 2014). Fourth, DE has been prospectively linked to symptoms
of depression, anxiety, and suicidality (Braun et al. 1994; Franko & Keel, 2006). Fifth, DE in
mid-adolescence is prospectively associated with the development of overweight and obesity at
6-year follow-up, independent of baseline or parental BMI (Herpertz-Dahlmann et al. 2015).
Sixth, DE can persist or increase from adolescence into adulthood (Kotler et al. 2001;
Neumark-Sztainer et al. 2011). A recent survey of 50 000 Australian females and males
aged 11–24 years (Mission Australia, 2010) found that body image ranked as the highest personal concern by 28.1% of 11–14 year-olds, 33.3% of 15–19 year-olds, and 40.3% of 20–24
year-olds. These studies suggest that body image and eating pathology are not limited to
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adolescence; rather, they increase during early adulthood. Clearly,
the burden and consequences of DE are immense and require efficacious risk reduction programs that can be easily disseminated
at-scale.
Prevention programs for DE usually occur across the spectrum
of universal (e.g. large groups of participants regardless of baseline
level of DE risk), selective [e.g. participants selected based on a
prospectively identified risk factor (e.g. females)], and indicated
(i.e. participant selection based on exhibiting clear precursors to
an ED such as elevated weight concerns). Three indicated risk
reduction programs have had favourable outcomes across multiple
randomized controlled trials (RCTs): The Body Project (Stice et al.
2000); Healthy Weight (Stice et al. 2001); and, Student Bodies (SB:
Winzelberg et al. 2000). The first two are delivered face-to-face,
while SB is delivered online with therapist moderation. For the
current study where the goal was to evaluate programs in a ‘realworld’ context, it was thought that online programs would be
more scalable at lower cost, thus SB was included. Since the commencement of this research, an online version of The Body Project
has been investigated (Stice et al. 2012).
Online risk reduction programs are becoming more common
across the DE prevention spectrum (e.g. see Melioli et al. 2016).
Online delivery holds the appeal of sidestepping two important
gaps in reducing the burden of mental illness (Patel et al. 2011;
Kazdin et al. 2017): the research-practice gap (efficacious delivery
of evidence-based programs in the real world); and, the treatment
gap (discrepancy between those who could benefit from services
and those who receive such services). Specifically, ‘pure self-help’
online interventions (i.e. no personalized online therapist moderator) do not require training of health providers to deliver – the
intervention is designed by the specialist, made available online
and then accessed directly by individuals at scale. As such, online
interventions have no limitation to the number of participants
who can participate, unlike face-to-face services that are bound
by the availability of service providers, training of these providers,
and, assumptions intervention fidelity is maintained.
SB has been evaluated in 11 RCTs, seven in the USA
(Winzelberg et al. 1998; Celio et al. 2000; Winzelberg et al.
2000; Bruning Brown et al. 2004; Low et al. 2006; Taylor et al.
2006; Kass et al. 2014; Taylor et al. 2016) and four in Germany
(Jacobi et al. 2005, 2007; Jacobi et al. 2012). These samples have
included young-adult or late adolescent females from college
and high-school settings. The most methodologically rigorous
trial was with college-aged women with elevated weight concerns
(M age = 20.8 years: Taylor et al. 2006), showing significant differences of moderate effect size (ES) at 1-year follow-up favouring
the SB for weight and shape concern, global measures of disordered eating, and ED risk factors. Although no main effects
were shown for prevention of ED onset, prevention effects were
found for two subsets of users at 2-year follow-up: those who
were overweight at baseline (i.e. SB = 0% v. controls = 10.8%);
and, at one site, amongst those engaging in compensatory behaviours at baseline (i.e. SB = 14.4% v. controls = 30%). A comparison of guided v. self-help versions of SB (conducted concurrently
to the current trial) found the guided group had significantly
lower weight concerns and lower odds of remaining at high risk
of an ED than the non-guided group at post-intervention (M
age = 20.1 years: Kass et al. 2014). While a recent RCT for
those at ‘very high risk’ of an eating disorder (Taylor et al.
2016) found amongst participants with high shape and weight
concerns, ED onset was significantly lower in the SB group compared with controls (SB = 20% v. controls = 42%).
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To date SB has not been compared with another intervention.
In the current study we compared it with Media Smart-Targeted
(MS-T), an adapted online version of an 8-lesson school-based
program (MS) that has been found to reduce ED risk factors relative to controls and active interventions in young-adolescent
(Grades 7 and 8) girls and boys (Wilksch & Wade, 2009;
Wilksch et al. 2015). MS is one of the most robust universal ED
risk reduction programs (Levine & Smolak, 2016; Piran, 2015)
and has been found to significantly lower shape and weight concerns in girls over a 2.5-year follow-up (Wilksch & Wade, 2009)
and halve the risk of onset of clinical concerns about shape and
weight at 12-month follow-up (Wilksch et al. 2015). The current
study was the first evaluation of MS-T.
The World Health Organization estimates 22 as the peak age
in the relative value of healthy lived years (Murray & Lopez,
1996) and thus DE risk reduction in young-adults is important
to ensure this peak productivity is not compromised and to prevent impairment over future years (Wade et al. 2012). Thus the
primary aim of this research was to evaluate the ‘real world’
effectiveness of an established online ED prevention program
(SB) relative to a new online program (MS-T) and a control condition with young-adult women. Related to this, we sought to
maximize the external validity of this research by: using a general community population as opposed to university and schoolbased settings typically investigated; and, allowing participants
with higher baseline levels of eating pathology than in previous
trials.
Methods
Participants
Participants were women aged 18–25 years from Australia and
New Zealand who wished to improve their body image.
Participants self-referred through advertisements posted around
university campuses, social media online, and, health clinic
waiting rooms. Exclusion criteria were minimal: suicide risk
[e.g. have a suicide plan (Lecrubier et al. 1997)]; alcohol or substance abuse [e.g. the presence of withdrawal effects when reducing use (Lecrubier et al. 1997)]; or, self-reported BMI < 15.0.
Women with premorbid DE were included in the study, to
reflect the real-world likelihood of such women accessing online
resources.
Conditions
SB has been described in detail (Winzelberg et al. 2000), as has
MS (Wilksch & Wade, 2009). SB and MS-T are 9-module programs that follow the principles of effective prevention, such as
interactive content and targeting prospectively identified ED
risk factors (Stice et al. 2007). Consistent with previous SB trials
(Taylor et al. 2016), both programs released modules weekly via
a password-protected mobile internet-platform and both programs were a pure self-help format (no online therapist moderator). The SB program was delivered in its usual form on a
mobile platform but without moderation. Participants were
encouraged to view content (e.g. written, video), respond to questions, and complete accompanying assignments. Supplementary
Table 1 provides a description of the programs. Both target weight
concerns, a robust and proximal ED risk factor (Jacobi et al. in
press), but do this in differing ways. SB focused on behavioural
targets (e.g. eating, exercise) that are proximal to DE in risk factor
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models while MS-T focused more on cognitive components (e.g.
media internalization, ineffectiveness) that are more distal in such
models (Stice, 2001; Fairburn et al. 2003).
The translation of MS to MS-T was guided by three rationale.
First, the theoretical targets of MS (media internalization) are
informed by the dual-pathway model, developed from risk factor
research with young-adult women and thus relevant to this population (Stice, 2001). Second, The Body Project also targets this
variable and has been found to be effective with this population
(Stice et al. 2009). Third, given that results for universal samples
are usually of a smaller effect than for university-aged, high-risk
samples (Stice et al. 2007), it was expected that MS-T could produce at least comparable outcomes to MS.
MS-T was developed over an 18-month process of: writing and
adapting each module to include age-appropriate content; pilot
testing; ensuring accurate data collection; and, further revisions.
For example where module 3 in MS provided a clip on standing
up to peer pressure on teen drinking, in MS-T this was replaced
by a post titled ‘You look so different on Facebook’ and then
examining strategies to reduce pressures felt from social media
usage. The new content included a focus on: emotion regulation,
goal setting, and ‘healthy eating’, which included four tips
informed by risk factor research: eat breakfast; eat regularly;
drink water; and, dieting as unhelpful. MS-T modules were
designed to be of comparable length and aesthetics to SB, to
reduce confounds. There was one difference of note: MS-T participants received an automated weekly email to advise their
module was available, whereas SB participants did not. The control condition involved one email containing 10 tips for improving body image as used in other targeted trials (e.g. Stice et al.
2011).

Procedure
Approval for this research was received from the Flinders
University Social and Behavioural Research Ethics Committee.
Potential participants were directed to the study website where
they were provided with information, consent procedures, and
baseline questionnaires. Upon completion and meeting inclusion
criteria, participants were automatically randomized to one of the
three groups. Randomization was stratified by age (18–21 years;
21.01 years- 25 years) and baseline scores on the Weight
Concerns Scale (<47; >47: WCS: Killen et al. 1994). A WCS
score of 47 or higher has been found to have a sensitivity of
79%, specificity of 67%, and positive predictive value of 13% for
identifying adolescents who developed partial- or full-syndrome
EDs (Jacobi et al. 2004).
Age was included as a proxy for duration of body image concerns (Rohde et al. in press). Whilst participants were accepted
across the WCS score spectrum in line with the pragmatic RCT,
we expected the majority of participants to score ⩾47.
Participants allocated to an intervention were able to access their
respective website immediately. All participants received an email
reminder to complete post-program measures 10-weeks after
baseline. This process was repeated at 6- and 12-month follow-up.
If a participant did not commence the measures at any time point
they received two further email reminders at weekly intervals.
Participants who completed a minimum of three assessment
points received a $50 gift voucher as reimbursement for their
time. Intervention participation was not a requirement for this
reimbursement.
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Measures
Primary outcome
The Eating Disorder Examination Questionnaire (EDE-Q) Global
was used to provide a continuous measure of eating pathology.
The use of the EDE-Q was consistent with the pragmatic, ‘pure
self-help’ nature of this trial where phone interview (i.e. EDE)
could deter participation and would be unlikely in real-world
implementation. The EDE-Q has only moderate diagnostic concordance against the EDE (Berg et al. 2012) and therefore diagnostic categories were not utilized.
Secondary outcomes
A range of risk factor and impairment measures in addition the
EDE-Q were selected based upon the evidence supporting their
construct validity (Sheehan et al. 1997; Espelage et al. 2003;
Jacobi et al. 2004; Thompson et al. 2004; Henry & Crawford,
2005; Berg et al. 2011; Vannucci et al. 2012) and their frequent
use in other prevention trials (e.g. Taylor et al. 2006; Wilksch &
Wade, 2009). Higher scores indicated higher levels of risk for
all but the quality of life mental scale, where a lower score indicated a poorer outcome (see Table 1).
Tertiary outcomes
Consistent with previous investigations (Bardone-Cone et al.
2010), DE was defined as having a global EDE-Q score ⩾1 SD
of the community mean (i.e. 2.46: Mond et al. 2004), and the
presence of one or more of the following in the previous
4-week period: objective bulimic episode; fasting; vomiting or
laxatives to control weight; or BMI < 18.5. Thus DE was a dichotomous outcome and allowed exploration of both prevention (DE
status at follow-up for those who did not have DE at baseline) and
treatment effects (DE status at follow-up for those who had DE at
baseline).
Statistical analyses
Participant flow, variables impacting intervention access and
baseline differences
Demographic details were investigated (e.g. age, living location)
using analysis of variance (ANOVA) and χ2 analyses. Potential
variables impacting on intervention access were examined univariately and then multivariately using linear regressions.
As data were only analyzed for those participants who accessed
their intervention, consistent with previous investigations (e.g.
Taylor et al. 2006), logistic regressions investigated baseline differences between participants who accessed their allocated intervention, v. those who did not. They were also used to compare rates
of module completion across interventions. Baseline differences
across the three groups were analyzed using ANOVAs for continuous measures and χ2 for dichotomous outcomes, with an
alpha level of 0.05.
Missing data and intervention completion rates
To determine whether data were missing at random, logistic
regressions were used to assess whether ‘measure completers’
(those who completed baseline measures and at least one other
assessment point, the minimum necessary given baseline was a
covariate in analyses) differed from those who only completed
baseline measures in the intervention conditions. Logistic regressions were also used to compare rates of module access and completion between MS-T and SB.

Downloaded from https://www.cambridge.org/core. Washington University School of Medicine - St Louis, on 04 Mar 2018 at 23:58:09, subject to the Cambridge Core terms of use, available at
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291717003567

4

Simon M. Wilksch et al.

Table 1. Summary and description of primary and secondary outcome self-report measures
Outcomes

Description (Cronbach’s alpha) and example item

Primary outcomes
Global EDE-Q

Eating Disorder Examination – Questionnaire (Fairburn & Beglin, 1994), 22 items (α = 0.94)
e.g. How dissatisfied have you been with your weight?, 0 = ‘Not at All’ to 6 = ‘Marked’

Secondary outcomes
Weight concerns

The Weight Concerns Scale (Killen et al. 1994) 5 items (α = 0.72)
e.g. Do you ever feel fat, 1 = ‘Never’ to 5 = ‘Always’, multiplied to generate score /100

Depression

Depression, Anxiety, Stress Scale (Lovibond & Lovibond, 1995), 21 items (depression α = 0.93; anxiety α = 0.85; stress α = 0.87)
e.g. I felt that I had nothing to look forward to, 0 = Not at All to 3 = Very much or most of the time

Media internalization

Sociocultural Attitudes Towards Appearance Questionnaire-3 (Thompson et al. 2004), 9 items (α = 0.95)
e.g. I compare my body to the bodies of TV and movie stars, 1 = ‘definitely disagree’ to 5 = ‘definitely agree’

Ineffectiveness

Eating Disorder Inventory (EDI: Garner et al. 1983) 10 items (α = 0.91)
e.g. I feel inadequate, 6 = ‘Always’ to 1 = ‘Never’

Clinical impairment

Clinical Impairment Assessment Questionnaire (Bohn & Fairburn, 2008), 16 items (α = 0.96)
e.g. To what extent has your exercise/eating habits/feelings about weight or shape made it difficult to concentrate? 0 = ‘Not at
all’ to 3 = ‘A lot’

Quality of life – mental

Medical Outcome Studies Short Form Scales – Mental Component Scale (Ware et al. 1993) ,5 items (α = 0.85)
e.g. Have you felt calm and peaceful, 100 = ‘strongly agree’ to 0 = ‘strongly disagree’

Risk – suicide, drug,
alcohol

MINI International Neuropsychiatric Interview (Lecrubier et al. 1997) 15 items.
e.g. In the past month did you think about suicide?, ‘No’ to ‘Yes’

Due to an error in the US web company hosting SB, program
usage data for n = 50 consecutive new SB participants over a
2.5-month period was not available. Thus there were no means
for identifying if these users accessed SB. Logistic regression analyses found no significant baseline differences between these n =
50 cases v. the other n = 140 SB participants for any outcome variable [e.g. EDE-Q Global: OR = 1.14, 95% CI (0.90–1.46)]. These
participants were omitted from all further analyses.
Primary and secondary outcomes
Linear mixed model (LMM) analyses, with baseline observations
used as a covariate to ensure that any observed effects for that
variable were due to changes at post-program and follow-up,
were used to compare the impact of the conditions. A 3 (group:
MS-T, SB, Control) × 3 (time: post-program, 6-month follow-up;
12-month follow-up) design was used, allowing for direct comparisons between the groups at post-program and follow-up
using Bonferroni-adjusted post-hoc analyses. Cohen’s d between
group ES with 95% confidence intervals (CI) were calculated
using means and standard errors from the LMM. Analyses were
run in two ways. First, intent-to-treat (ITT) analyses included
all participants who accessed their intervention at least once
(MS-T = 122; SB = 98) and all controls (n = 194; Total N = 414),
regardless of if the participant completed any further measures
after baseline. These ITT analyses were conducted using multiple
imputation (MI) in SPSS to estimate missing values using
Bayesian analysis (Enders, 2010). The imputation step of the procedure used all the outcome variables at each assessment and
the number of modules completed (the control group was scored
as having completed no modules). MI incorporates postrandomization variables that are not part of the analysis model
(intervention models completed) in the imputation step and so

enable an analysis that is valid under a more realistic missing at
random assumption (Sterne et al. 2009). Five data sets were
imputed. Second, using all available data for measure completers
(MS-T = 82; SB = 70; controls n = 169; N = 321).
Tertiary outcomes
Both prevention (DE status for those who did not have DE at
baseline, N = 92) and treatment effects (DE status for those who
had DE at baseline, N = 169) were investigated for measure completers at 12-month follow-up. Odds ratios (OR) and 95% CI
from logistic regressions were used to compare DE status at
12-month follow-up in the intervention groups relative to the
control group. These analyses were also run adjusting for receiving any external professional treatment (e.g. psychologist, psychiatrist) at any of the four assessment points.
Results
Participant flow
Participant flow can be seen in Fig. 1. Recruitment occurred over
a 12-month period between 3 November 2014 and 1 November
2015, with the final 12-month follow-up assessment completed
on 29 December 2016. N = 608 women (M age = 20.71 years,
SD = 2.26, range 18–25 years) completed baseline measures,
with 33 participants excluded due to one or more of the following:
suicide risk (n = 8); alcohol abuse (n = 11); substance abuse (n =
20); and, BMI < 15.0 (n = 3). Thus N = 575 were randomized to
MS-T, SB or control.
The most common sources of recruitment were: flyers at universities and colleges (n = 179; 29.7%); social media (n = 164;
27.2%); and, media reports (n = 114; 18.9%). Participants lived
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Fig. 1. Participant flow chart.

in each state and territory of Australia (n = 460) and NZ (n = 144).
Capital cities (n = 362; 59.7%) were the most common location
followed by regional towns (n = 207; 34.2%). Current undergraduate was the most common education level (n = 229; 37.9%), followed by completion of year 12 (n = 169; 27.9%) and completion
of the undergraduate degree (n = 169; 18.8%). Ethnicity included:
Caucasian – Australian (n = 367; 60.4%), followed by Caucasian –
NZ (n = 131; 21.7%), and Asian (n = 53; 8.8%).
Variables impacting on intervention access
Five variables were significantly associated with likelihood of
accessing an intervention: age [OR = 1.14, 95% CI (1.02–1.27)];
attitude towards program participation [OR = 0.53, 95% CI
(0.35–0.82)]; EDE-Q – Global [OR = 1.21, 95% CI (1.02–1.44)];
clinical impairment [OR = 1.03, 95% CI (1.01–1.05)]; and quality
of life – mental [OR = 0.99, 95% CI (0.98–1.00)]. Attitude towards
program participation was the only predictor to remain significant [OR = 0.56, 95% CI (0.37–0.86)] in a simultaneous multiple
regression, where participants were significantly more likely to
access the intervention if they identified themselves as ‘committed
to trying the program’.
Baseline measures
Table 2 presents baseline scores by group for those who accessed
their intervention (MS-T = 122; SB = 98) and controls (n = 194).
No significant differences were found.
Missing data
No significant differences were found between intervention participants who completed more than one assessment point (n = 150:
MS-T = 82; SB = 68) and those who completed baseline only

(n = 70: MS-T = 40; SB = 30). EDE-Q Global [OR = 1.05, 95% CI
(0.85–1.29)], risk factors [e.g. internalization: OR = .87, 95% CI
(0.64–1.17)], BMI [OR = 1.25, 95% CI (0.78–1.99)], and, DE
[OR = .81, 95% CI (0.50–1.33)], were all non-significant. There
was no significant difference in rates of post-program and
follow-up measure completion between MS-T and SB [OR = .90,
95% CI (0.51–1.60)]. Module completion was significantly positively associated with assessment completion at post-program
and follow-up [OR = 2.02, 95% CI (1.44–2.84)], indicating the
inclusion of module completion as a variable in the determination
of MI.

Intervention completion
Table 2 presents completion rates of each module for SB (n = 140)
and MS-T (n = 191). A total of n = 111 (33.5%: SB = 42 + MS-T =
69 = 111/331) of participants did not open their allocated intervention. There were no significant differences in rates of first
accessing the interventions or completion of module 1. From
module 2 through 9, a significantly higher proportion of participants completed MS-T than SB. Of the participants who completed module 1 of their programs (SB = 63; MS-T = 63), n = 2
(3.2%) and n = 26 (41.2%) completed the full SB and MS-T programs, respectively.

Primary outcome
ITT analyses found no significant differences in EDE-Q Global
outcomes across the three groups (see Table 3). Measure completer analyses found MS-T participants had significantly lower
EDE-Q Global scores than controls at 12-month follow-up.
Main effects for group favouring MS-T were found for comparisons with both the control and SB groups. ES were small.
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Table 2. Rates of access and completion of Student Bodies and Media Smart-Targeted and baseline scores across conditions
SB (n = 140)

MS-T (n = 191)

Odds ratio (95% CI)

Opened module 1

98 (70%)

122 (63.9%)

0.76 (0.48–1.21)

Completed module 1

63 (45%)

63 (32.9%)

0.60 (0.38–0.94)

Completed module 2

17 (12.1%)

54 (28.3%)

2.85 (1.57–5.18)

Completed module 3

8 (5.7%)

40 (20.9%)

4.37 (1.98–9.67)

Completed module 4

7 (5.0%)

39 (20.4%)

4.88 (2.11–11.26)

Completed module 5

4 (4.3%)

31 (16.2%)

6.59 (2.27–19.13)

Completed module 6

4 (2.9%)

34 (17.8%)

7.36 (2.55–21.28)

Completed module 7

4 (2.9%)

26 (13.6%)

5.36 (1.83–15.73)

Completed module 8

4 (2.9%)

28 (14.7%)

5.84 (2.00–17.06)

2 (1.4%)

26 (13.6%)

10.87 (2.54–46.63)

SB (n = 98)

MS-T (n = 122)

Completed module 9

Controls (n = 194)

Odds Ratio (95% Confidence Interval)/F value

ED treatment in last 12 months

11 (11.2%)

18 (14.8%)

32 (16.7%)

χ (2) = 1.52, p = 0.467

Psychiatric medication

17 (17.7%)

25 (20.5%)

30 (15.5%)

χ (2) = 1.27, p = 0.530

Suicidal thoughts

28 (28.9%)

35 (28.7%)

49 (25.7%)

χ (2) = 0.50, p = 0.779

Non suicidal self-harm

18 (18.6%)

18 (14.8%)

30 (15.7%)

χ (2) = 0.62, p = 0.734

Age (years)

20.89 (2.29)

21.05 (2.20)

20.65 (2.29)

F (2,410) = 1.23, p = 0.293

BMI

24.11 (7.52)

24.57 (7.17)

24.20 (7.00)

F (2,411) = 0.15, p = 0.864

3.55 (1.26)

3.35 (1.42)

3.20 (1.40)

F (2,407) = 1.87, p = 0.156

68.42 (20.93)

66.00 (21.40)

64.05 (22.24)

F (2,404) = 1.31, p = 0.270

Global EDE-Q (0–6)
Weight concerns (0–100)
Weight concerns ⩾47

149 (78.8%)

χ (2) = 0.92, p = 0.955

DASS – Total (0–3)

1.15 (0.64)

1.07 (0.61)

1.04 (0.67)

F (2,410) = 1.06, p = 0.348

Media internalization (1–5)

3.65 (1.02)

3.55 (0.95)

3.53 (1.02)

F (24 007) = .46, p = 0.633

Ineffectiveness (1–6)

96 (78.7%)

77 (80.2%)

3.71 (1.05)

3.57 (0.98)

3.41 (1.00)

F (2,409) = 3.02, p = 0.050

Quality of life – mental (0–100)

49.44 (20.17)

51.30 (18.87)

52.29 (19.58)

F (2,410) = 2.27, p = 0.105

Clinical impairment (0–48)

23.10 (12.38)

22.03 (12.89)

20.62 (12.95)

F (2,408) = 1.30, p = 0.275

DE

72 (73.4%)

79 (64.8%)

121 (62.7%)

χ (2) = 5.09, p = 0.079

Note: ED, eating disorder; BMI, body mass index; EDE-Q, eating disorder examination – questionnaire; DASS, depression, anxiety, stress scale; DE, disordered eating case. Bonferroni-adjusted
p value for multiple testing in rates of module completion (0.05/9) to p = 0.06. Frequencies (and percentages) are reported for dichotomous variables while means (and standard deviations)
are provided for continuous measures. Bolded values indicate significant odds ratios ( p < 0.05)

Secondary outcomes
ITT analyses revealed significant effects of small ES for two variables. Specifically, SB participants had significantly higher levels
of clinical impairment at post-program than both MS-T and controls. MS-T participants had significantly higher quality of lifemental at 6-month follow-up than both controls and SB (see
Table 3). Amongst measure completers, MS-T participants
reported significantly lower scores than both controls and SB on
5 variables with ES ranging from small to medium in magnitude:
depression (6- and 12-month follow-up); internalization (postprogram); ineffectiveness (12-month follow-up); clinical impairment (12-month follow-up); and quality of life mental (6-month
follow-up). MS-T participants also scored significantly higher
than SB at each assessment point for the quality of life – mental.
Tertiary outcomes
Prevention effects
Of measure completer participants with 12-month follow-up data,
a total of n = 15 met DE criteria who did not meet DE at baseline

(n = 92). Table 4 provides the frequency and percentage of participants from each group that developed DE at 12-month
follow-up. It shows MS-T and SB participants had an 85% and
69% lower likelihood than controls of becoming a new DE case
at 12-month follow-up respectively. Amongst those who did not
seek external treatment at any point in the study, MS-T and SB
participants were 78% and 55% less likely than controls respectively to become a new DE case at 12-month follow-up. No results
relating to prevention effects were significant.
Treatment effects
Of measure completer participants with 12-month follow-up data,
a total of n = 52 no longer met DE criteria who did meet DE at
baseline (n = 169). Table 4 shows MS-T participants who met criteria for eating pathology at baseline had a significantly lower likelihood than controls of still meeting criteria at 12-month
follow-up, including when adjusting for accessing ED treatment.
Amongst those who did access external ED treatment, MS-T participants were seven times less likely than controls to meet DE criteria at 12-month follow-up. The comparison between SB and
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ITT sample (n = 414)

Outcomes

Post-program
d (95% CI)

Measure Completer sample (n = 284)

6-month follow-Up
d (95% CI)

12-month follow-Up
d (95% CI)

Overall group
comparison d (95% CI)

−0.10 (−0.32 to 0.13)

−0.09 (−0.31 to 0.14)

−0.13 (−0.36 to 0.09)

Post-program
d (95% CI)

6-month follow-up
d (95% CI)

12-month follow-up
d (95% CI)

Overall group
comparison
d (95% CI)

−0.33 (−0.63 to −0.03)

−0.31 (−0.59 to −0.02)

Primary Outcome

Psychological Medicine

EDE-Q Global
MS-T v. Con
SB v. Con

−0.07 (−0.30 to 0.16)
0.08 (−0.16 to 0.32)

0.09 (−0.15 to 0.34)

−0.14 (−0.41 to 0.12)

−0.19 (−0.46 to 0.08)

MS-T v. Con

−0.16 (−0.39 to 0.07)

.01 (−0.21 to 0.24)

SB v. Con

−0.14 (−0.38 to 0.10)

MS-T v. SB

−0.01 (−0.28 to 0.26)

MS-T v. Con
SB v. Con

0.11 (−0.13 to 0.35)

0.14 (0.10 to 0.38)

0.03 (−.27 to 0.32)

−0.20 (−0.49 to 0.08)
0.10 (−0.21 to 0.41)

0.02 (−0.28 to 0.32)

0.06 (−0.24 to 0.35)

−0.24 (−0.51 to −0.03)

−0.25 (−0.59 to 0.10)

−0.31 (−0.66 to 0.05)

0.03 (−0.20 to 0.25)

−0.04 (−0.27 to 0.18)

−0.14 (−0.43 to 0.14)

.08 (−0.21 to 0.38)

−0.01 (−0.25 to 0.23)

0.00 (−0.24 to 0.24)

−0.07 (−0.31 to 0.18)

−0.13 (−0.43 to 0.16)

0.02 (−0.25 to 0.28)

0.03 (−0.24 to 0.29)

0.02 (−0.25 to 0.28)

−0.01 (−0.35 to 0.34)

0.10 (−0.12 to 0.33)

−0.05 (−0.30 to 0.17)

−0.01 (−0.23 to 0.22)

0.02 (−0.21 to 0.25)

0.04 (−0.24 to 0.33)

−0.33 (−0.62 to 0.03)

−0.32 (−0.62 to −0.02)

0.15 (−0.09 to 0.39)

0.07 (−0.18 to 0.31)

0.19 (−0.05 to 0.43)

0.18 (−0.06 to 0.43)

0.15 (−0.15 to 0.44)

0.11 (−0.20 to 0.42)

0.22 (−0.08 to 0.52)

0.21 (−0.09 to 0.54)

−0.05 (−0.31 to 0.22)

−0.11 (−0.38 to 0.15)

−0.18 (−0.45 to 0.09)

−0.17 (−0.43 to 0.10)

−0.14 (−0.48 to 0.21)

−0.45 (−0.81 to −0.09)

−0.56 (−0.93 to 0.20)

−0.47 (−0.81 to −0.12)

MS-T v. Con

−0.17 (−0.40 to 0.05)

−0.04 (−0.27 to 0.18)

−0.01 (−0.24 to 0.21)

−0.11 (−0.34 to 0.12)

−0.33 (−0.61 to −0.04)

−0.07 (−0.37 to 0.22)

−0.15 (−0.45 to 0.15)

−0.22 (−0.51 to 0.56)

SB v. Con

−0.05 (−0.30 to 0.19)

−0.03 (−0.28 to 0.21)

−0.15 (−0.39 to 0.09)

−0.11 (−0.36 to 0.13)

0.03 (−0.26 to 0.33)

MS-T v. SB

−0.11 (−0.38 to 0.16)

−0.02 (−0.28 to 0.25)

0.09 (−0.17 to 0.36)

−0.01 (−0.28 to 0.25)

−0.36 (−0.71 to −0.02)

−0.15 (−0.51 to 0.20)

−0.05 (−0.41 to −0.31)

−0.23 (−0.57 to 0.12)

−0.03 (−0.26 to 0.20)

−0.05 (−0.27 to 0.18)

−0.08 (−0.30 to 0.15)

−0.03 (−0.25 to 0.20)

−0.05 (−0.33 to 0.24)

−0.19 (−0.48 to 0.11)

−0.32 (−0.62 to −0.02)

−0.22, (−0.51 to 0.06)

0.03 (−0.21 to 0.28)

0.04 (−0.20 to 0.28)

0.08 (−0.16 to 0.32)

0.05 (−0.19 to 0.29)

0.23 (−0.06 to 0.53)

0.13 (−0.18 to 0.43)

−0.07 (−0.33 to 0.20)

−0.10 (−0.36 to 0.17)

−0.14 (−0.40 to 0.13)

−0.07 (−0.34 to 0.19)

−0.30 (−0.64 to 0.04)

−0.04 (−0.27 to 0.18)

−0.02 (−0.25 to 0.21)

−0.08 (−0.31 to 0.14)

−0.06 (−0.29 to 0.16)

−0.06 (−0.34 to 0.22)

MS-T v. SB

−0.16 (−0.43 to .11)

−0.22 (−0.50 to 0.07)

−0.35 (−71 to 0.01)

−0.37 (−0.71 to 0.02)

−0.14 (−0.44 to 0.16)

−0.08 (−0.36 to 0.20)

−0.02 (−0.32 to 0.29)

−0.03 (−0.33 to 0.26)

−0.07 (−0.37 to 0.22)

0.10 (−0.26 to 0.46)

−0.11 (−0.46 to 0.25)

−0.01(−0.35 to 0.34)

Secondary outcomes
WCS

DASS Total

MS-T v. SB

−0.25 (−0.54 to 0.03)

SATAQ-3

0.07 (−0.23 to 0.39)

−0.12 (−0.48 to 0.24)

0.00 (−0.29 to 0.30)

Ineffectiveness
MS-T v. Con
SB v. Con
MS-T v. SB

0.15 (−0.15 to 0.45)

0.16 (−0.14 to 0.45)

−0.32 (−0.68 to 0.04)

−0.51 (−0.88 to −0.15)

−0.39 (−0.73 to −0.04)

−0.12 (−0.42 to 0.17)

−0.39 (−0.69 to −0.08)

−0.23 (−0.51 to 0.06)

Clinical
impairment
MS-T v. Con
SB v. Con
MS-T v. SB

0.29 (0.05–0.53)
−0.36 (−0.63 to −0.10)

0.00 (−0.24 to 0.24)

0.10 (−0.14 to 0.35)

0.16 (−0.09 to 0.40)

−0.01 (−0.28 to 0.25)

−0.18 (−0.45 to 0.08)

−0.18 (−0.42 to 0.07)

0.36 (0.06–0.65)
−0.42 (−0.77 to 0.07)

0.16 (−0.15 to 0.47)
−0.29 (−0.65 to 0.07)

0.21 (−0.09 to 0.51)

0.28 (−0.01 to 0.58)

−0.61 (−0.97 to −0.24)

−0.52 (−0.87 to −0.17)

QOL-M
MS-T v. Con
SB v. Con
MS-T v. SB

0.15 (−0.07 to 0.38)
−0.14 (−0.37 to 0.09)
0.24 (−0.02 to 0.51)

0.24 (0.02–0.47)
−0.12 (−0.37 to 0.12)
0.34 (0.08 to 0.61)

−0.01 (−0.24 to 0.21)

0.18 (−0.05 to 0.40)

0.28 (−0.01 to 0.56)

−0.16 (−0.40 to 0.09)

−0.20 (−0.44 to 0.05)

−0.18 (−0.47 to 0.12)

0.14 (−0.13 to 0.40)

0.31 (0.05–0.58)

0.46 (0.11–81)

0.44 (0.14–0.73)
−0.14 (−0.45 to 0.17)
0.59 (0.22–0.95)

0.28 (−0.02 to 0.58)
−0.16 (−0.46 to 0.14)
0.46 (0.10–0.82)

0.41 (0.12–0.69)
−0.19 (−0.49 to 0.10)
0.61 (0.26–0.96)
(Continued )
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Table 3. Effect sizes (Cohen’s d) for between-groups pairwise comparisons for primary and secondary outcomes

−0.03 (−0.38 to 0.31)
−0.29 (−0.65 to 0.07)
0.11 (−0.15 to 0.38)
−0.06 (−0.32 to 0.21)
MS-T v. SB

−0.20 (−0.47 to 0.07)

−0.08 (−0.35 to 0.18)

−0.04 (−0.38 to 0.31)

0.30 (−0.06 to 0.66)

0.13 (−0.17 to 0.42)

Note: MS, Media Smart; SB, Student Bodies; Con=, control; CI=, confidence intervals; EDE-Q, eating disorder examination- questionnaire; WCS, weight concerns scale; DASS, depression, anxiety, stress scales; SATAQ-3, sociocultural attitudes towards
appearance questionnaire-3; QOL-M, quality of life – mental; BMI, body mass index; ITT, intent-to-treat sample using multiple imputation for missing data; Measure completer sample, participants who completed baseline and at least one other
assessment point. For continuous outcomes, a negative d indicates group 1 scoring at lower risk than group 2 for all measures apart from QOL-M, where a positive d indicates group 1 had a higher QOL-M. Between-group comparisons that are
significantly different are bolded ( p < 0.05). *12-month follow-up frequencies for new disordered cases at 12-month follow-up that did not meet diagnosis at baseline. ^12-month follow-up frequencies for cases who did meet disordered eating diagnosis
at baseline but who did not meet diagnosis at 12-month follow-up. Between-group comparisons that are significantly different are bolded ( p < 0.05)

0.09 (−0.19 to 0.38)

0.26 (−0.04 to 0.56)

0.18 (−0.11 to 0.48)

−0.11 (−0.42 to 0.20)
0.13 (−0.16 to 0.43)

0.10 (−0.19 to 0.38)
BMI

0.11 (−0.14 to 0.35)

0.02 (−0.21 to 0.25)
−0.05 (−0.28 to 0.18)

0.00 (−0.24 to 0.24)
0.06 (−0.18 to 0.31)
SB v. Con

0.12 (−0.11 to 0.34)
0.01 (−0.22 to 0.23)
MS-T v. Con

12-month follow-Up
d (95% CI)
6-month follow-Up
d (95% CI)
Post-program
d (95% CI)
Outcomes

0.18 (−0.06 to 0.35)

12-month follow-up
d (95% CI)
6-month follow-up
d (95% CI)
Overall group
comparison d (95% CI)

Post-program
d (95% CI)

Measure Completer sample (n = 284)
ITT sample (n = 414)
Table 3. (Continued.)

−0.02 (−0.32 to 0.28)

Simon M. Wilksch et al.

Overall group
comparison
d (95% CI)
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controls was not significant. Supplementary Table 2 provides
breakdowns of specific DE behaviours.
Discussion
The aim of this pragmatic RCT was to assess the real-world effectiveness of two online DE prevention programs. This study differed to earlier trials in that: participants were sought from the
broader community; programs were pure ‘self-help’ rather than
moderated by a personalized online therapist; and, less exclusion
criteria for eating pathology were used.
What type of participants enrolled and accessed their
allocated intervention?
Participants were experiencing higher levels of baseline eating
pathology than any previous SB trial (EDE-Q Global M = 3.37),
including those ‘at very high risk’ of an eating disorder (M =
2.31: Taylor et al. 2016), and clinical impairment scores (M =
21.61: Bohn & Fairburn, 2008) were in the clinical range (⩾16).
This mimics how these interventions might be used in community settings, where website access would not be limited and
where those with greater pathology might be more likely to access
interventions.
While higher pathology and clinical impairment were associated with greater likelihood of accessing the intervention, the
only unique predictor was identification as being ‘committed to
trying the program’. One-third of participants allocated to SB
(30.0%) or MS-T (36.1%) never opened the website, consistent
with the median engagement level of 38% found in a review of
online engagement (Waller & Gilbody, 2009). There could be
value in providing brief motivation enhancement strategies at
the completion of baseline measures to increase the likelihood
of accessing a program. Alternatively, motivation could be an
inclusion criterion, recommending guided or face-to-face options
to those who are less motivated.
Rates of intervention completion were low. Of those who
opened their allocated intervention, 51.6% (63/122) and 64.3%
(63/98) completed module 1 of MS-T and SB, respectively, with
attrition for SB significantly greater than for MS-T and the full
MS-T program completed at a 10-fold higher rate than SB.
Modules were released weekly, in line with earlier SB trials, as it
was hoped that this would give participants time to complete
homework and consolidate learning. However, this might have
been a deterrent to some and future trials could investigate
whether allowing open access to the full intervention is associated
with greater completion. Also, MS-T participants received an
automated weekly email alert that their next module was available,
whereas SB participants did not, suggesting that reminders result
in higher completion rates. The early and high drop-off rates for
SB were inconsistent with previous SB trials. In the most comparable study, Kass et al. (2014) reported that approximately half the
participants in an unmoderated group completed at least half the
SB program, much higher usage than observed in the current trial.
The Kass et al. trial included journal log prompts and guided discussions, both of which may reinforce participation.
MS-T was designed to be aesthetically similar to SB with
comparable module length and learning activities, thus it is
unlikely that the differing completion rates were due to program
appearance factors. One explanation relates to the difference in
the way weight concerns were targeted: SB initially focuses on a
variety of cognitive issues related to body image with a focus on
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Table 4. Tertiary outcomes, presence of disordered eating at 12-month follow-up (significant results are bolded)

Analysis

MS-T
N (%)

SB
N (%)

Control
N (%)

OR (95% CI)
MS-T v. control

OR (95% CI)
SB v. control

13/57 (22.8)

0.15 (0.02–1.25)

0.31 (0.04–2.61)

0.23 (0.03–1.94)

0.46 (0.05–4.03)

0.22 (0.03–1.93)

0.45 (0.05–4.03)

Prevention effectsa
1. Not adjusting for treatment

1/23 (4.3)

1/12 (8.3)

2. Adjusting for treatment
No treatment

1/23 (4.3)

1/12 (8.3)

8/48 (16.7)

Yes treatment

–

–

5/9 (55.6)

16/37 (43.2)

15/45 (33.3)

21/87 (24.1)

0.41 (0.18–0.94)

0.63 (0.29–1.40)

No treatment

11/28 (39.3)

13/34 (38.2)

18/67 (26.9)

0.57 (0.22–1.44)

0.59 (0.25–1.43)

Yes treatment

5/9 (55.6)

2/11 (18.2)

3/20 (15.0)

0.14 (0.02–0.85)

0.79 (0.11–5.66)

–

–

Treatment effectsb
1.Not adjusting for treatment
2. Adjusting for treatment

0.42 (0.19–0.94)

0.64 (0.29–1.40)

a

Note: Proportion per condition of new cases of disordered eating at 12-month follow-up: only participants who did not have DE at baseline.
b
Proportion per condition of no longer being a disordered eating case: only participants who did have DE at baseline. Bolded values indicate significant odds ratios ( p < 0.05)

self-directed behavioural change in later modules; while MS –T
focuses on critiquing media messages and developing strategies
to resist these and related pressures. Whilst completion rates
were low making it difficult to draw conclusions about the program targets, it could be that MS-T participants found their
content of personal relevance, which might explain higher
completion rates.

What were the outcomes for those who accessed their
allocated intervention?
ITT analyses revealed minimal differences in outcomes across the
groups and no differences at 12-month follow-up. No significant
effect was found for the primary outcome (EDE-Q Global) and
only two effects for secondary outcome variables with low ES MS-T participants reported higher quality of life–mental relative
to both controls and SB (6-month follow-up), and MS-T and controls had lower clinical impairment relative to SB (post-program).
These minimal differences are likely explained by low rates of
intervention completion.
SB did not perform as well as previous findings (e.g. Jacobi
et al. 2012; Taylor et al. 2016), though findings are difficult to
interpret given very low completion rates. The most likely reason
for this was the absence of a personalized online moderator,
which has previously been recommended as an important for
internet interventions to work (Andersson et al. 2009). This is
consistent with the recent comparison of guided v. self-help versions of SB where the guided group had superior outcomes (Kass
et al. 2014). Second, SB was implemented and hosted by a different web team in the USA than earlier trials and did not support
some basic features of the program, such as notifications and
interactivity or feedback. At the time of this trial, the team was
working on a number of larger SB trials where it is possible
that program delivery in the current trial was sub-optimal.
Of those who did access their intervention, MS-T achieved
some promising results. For the measure completer sample,
MS-T participants reported significant benefits relative to both
controls and SB at varying time points for EDE-Q Global, depression, ineffectiveness, clinical impairment, media internalization,
and quality of life – mental. Amongst measure completers at

12-month follow-up, MS-T participants reported significantly
lower Global EDE-Q scores than controls and lower levels than
both controls and SB for depression (also at 6-month follow-up);
ineffectiveness; and, clinical impairment. Given measure completion was twice as likely by those who completed more modules
than those who did not, these findings suggest participants
needed to participate in MS-T to experience benefit.
Whilst not significant, MS-T participants who did not meet
DE criteria at baseline were 85% less likely than controls to
meet criteria at 12-month follow-up. The rates of reduction in
onset of eating pathology were comparable with that found for
face-to-face delivery of The Body Project (60%) and Healthy
Weight (61%) and in earlier trials of SB (88% for those with elevated BMI at baseline: Taylor et al. 2006), though these respective
findings were over a 2–3 year follow-up (Stice et al. 2008b) using
diagnostic criteria. Of those who met DE criteria at baseline, those
in the MS-T group were significantly less likely (59%) than controls to still meet diagnosis at 12-month follow-up, including controlling for accessing external ED treatment. To the best of our
knowledge, this was the first time a program has achieved a treatment effect of this type. Most previous studies have excluded participants with elevated levels of baseline eating pathology. MS-T is
well-suited to a clinical population given that the program is not
face-to-face and it does not include open discussion groups where
other participants could be exposed to the unhelpful content. It
was of interest that amongst those who did access external ED
treatment, MS-T participants were 85% less likely than controls to
have DE at 12-month follow-up. This suggests that MS-T might
augment treatment response and warrants further investigation.

Limitations and strengths
Four limitations were present in this study, the first two related to
the pragmatic RCT approach. First, measure completion was selfreport rather than an interview which has been used in other prevention trials (e.g. Taylor et al. 2006). Second, rates of measure
completion were lower than in other targeted prevention trials
where this was likely exacerbated by online self-report assessment
and findings for the ITT analyses should be interpreted cautiously. Third, the lost program usage data for n = 50 new SB
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participants was beyond our control and this was managed in a
conservative fashion (i.e. confirming no differences between
these and the remaining SB participants and omitting from analyses). Finally, the follow-up period was shorter than some previous prevention trials (Wilksch & Wade, 2009)
There were also strengths, including the: evaluation of multiple
programs by two research groups; a large, community-based sample recruited in just 12-months; minimal exclusion criteria allowing for investigation of outcomes by those with pre-existing eating
pathology; and, the inclusion of indicators of clinical impairment.
Whilst the fully automated online screening and program allocation procedures allowing for real-world application with minimal
cost were also a strength, strategies for increasing user engagement
and reducing dropout need to be explored. Of the two programs,
SB is a far more established program that has shown consistent
benefit in previous trials and is likely better suited to guided delivery using a personalized online therapist. The results indicate that
MS-T shows promise as a ‘pure self-help’ program where further
investigations are indicated.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291717003567
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